Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Degron Therapeutics pioneers the exploration and advancement of targeted protein degradation therapeutics through small molecule molecular glue degraders (MGDs). With a cadre of esteemed scientific minds and seasoned industry experts, Degron leverages its profound expertise to pinpoint and validate MGD targets, especially those pivotal in disease pathogenesis yet challenging to drug via traditional modalities.

List your booth number for exhibitions, ask us